Citation: Sr. Norrby et al., CEFPIROME VERSUS CEFTAZIDIME AS EMPIRICAL SEPSIS TREATMENT, Diagnostic microbiology and infectious disease, 31(3), 1998, pp. 499-500
Citation: Sr. Norrby et al., RANDOMIZED COMPARATIVE TRIAL OF CEFPIROME VERSUS CEFTAZIDIME IN THE EMPIRICAL-TREATMENT OF SUSPECTED BACTEREMIA OR SEPSIS, Journal of antimicrobial chemotherapy, 42(4), 1998, pp. 503-509
Authors:
NORRBY SR
PETERMANN W
WILLCOX PA
VETTER N
SALEWSKI E
Citation: Sr. Norrby et al., A COMPARATIVE-STUDY OF LEVOFLOXACIN AND CEFTRIAXONE IN THE TREATMENT OF HOSPITALIZED-PATIENTS WITH PNEUMONIA, Scandinavian journal of infectious diseases, 30(4), 1998, pp. 397-404
Citation: Sr. Norrby, GREPAFLOXACIN IN RESPIRATORY-TRACT INFECTIONS - ARE WE READY TO ACCEPT A QUINOLONE FOR EMPIRICAL-TREATMENT, Journal of antimicrobial chemotherapy, 40, 1997, pp. 99-101
Authors:
AHONEN A
KOSKINEN R
RANTANEN P
BILLHEDEN J
BRATHEN G
BRIEM H
CRONBERG S
HAIDL S
ELMRUD H
BANKE S
FORSBERG P
HANNINEN P
HEDSTROM SA
ERNTELL M
LAHDEVIRTA J
HAKULINEN A
SIIKAMAKI H
LINDAHL L
NERINGER R
EKLUND PO
NORRBY SR
SCHLIAMSER SE
PERMIN H
SALMI HA
GERLINPIIRA L
KLEMETS P
LINDHOLM L
POLLONEN MP
ROSENGREN LM
SINASALO JP
TAKAL A
YLIAPALOSAARI P
SEEFELDTNIELSEN T
TARP B
SODERSTROM C
TAURIS P
TIKKINEN J
WALSTAD RA
THOMASSEN T
Citation: A. Ahonen et al., ATYPICAL PNEUMONIA IN THE NORDIC COUNTRIES - ETIOLOGY AND CLINICAL-RESULTS OF A TRIAL COMPARING FLEROXACIN AND DOXYCYCLINE, Journal of antimicrobial chemotherapy, 39(4), 1997, pp. 499-508
Authors:
GERSTOFT J
MELANDER H
BRUUN JN
PEDERSEN C
GOTZSCHE PC
BERGLUND O
MATHIESEN L
SKINHOJ P
NORRBY SR
Citation: J. Gerstoft et al., ALTERNATING TREATMENT WITH DIDANOSINE AND ZIDOVUDINE VERSUS EITHER DRUG ALONE FOR THE TREATMENT OF ADVANCED HIV-INFECTION - THE ALTER STUDY, Scandinavian journal of infectious diseases, 29(2), 1997, pp. 121-128
Authors:
JEWESSON PG
NABER KG
DUPONT HL
NORRBY SR
DELLAMONICA P
Citation: Pg. Jewesson et al., THE ROLE OF PEFLOXACIN IN COMMUNITY-ACQUIRED AND HOSPITAL-ACQUIRED INFECTIONS - QUESTIONS AND ANSWERS, Clinical drug investigation, 11, 1996, pp. 43-47
Authors:
DAUTZENBERG B
OLLIARO P
RUF B
ESPOSITO R
OPRAVIL M
HOY JF
ROZENBAUM W
CAROSI GP
MICOUD M
LAGE M
PIROTTA N
SASSELLA D
COULAUD JP
VILDE JL
GENTILINI M
CAUBARRERE I
CAQUET R
WEINBRECK P
LEBEAU B
HUMBERT G
MODAI J
ARMENGAUD M
DUFFAUT M
DUJARDIN P
DELLAMONICA P
MOUTON Y
GALLAIS H
GASTAUD JA
GENIAUX M
SUERI L
BARNI C
CALIGARIS S
ELHAMAD I
ERRANTE I
MORONI M
FRANZETTI F
CARGNEL A
DEDIVITIIS GF
MARONE P
PASTICCI MB
HELM EB
RUHNKE M
SCHURMANN D
SCHULER W
ERCKENBRECHT I
HEISE W
BROCKMEYER N
DIETRICH M
JONES P
GROSSET J
PENATI V
MAUCH H
SALFINGER M
DWYER B
GILBERT L
DESLANDES JY
DOLFI L
GLANZMANN I
HARRIS M
HERCEG R
LANDI V
MORELLI P
SCOLA E
WEINIG S
KUNIN MC
CARBON NC
GRASSI G
NORRBY SR
POCOCK SJ
Citation: B. Dautzenberg et al., RIFABUTIN VERSUS PLACEBO IN COMBINATION WITH 3 DRUGS IN THE TREATMENTOF NONTUBERCULOUS MYCOBACTERIAL INFECTION IN PATIENTS WITH AIDS, Clinical infectious diseases, 22(4), 1996, pp. 705-708
Citation: J. Berglund et al., LONG-TERM STUDY OF LYME BORRELIOSIS IN A HIGHLY ENDEMIC AREA IN SWEDEN, Scandinavian journal of infectious diseases, 28(5), 1996, pp. 473-478
Authors:
LYON DJ
SCHEEL O
ADEYEMIDORO FAB
LING TKW
CHENG AFB
NORRBY SR
Citation: Dj. Lyon et al., ANTIMICROBIAL SUSCEPTIBILITY AND EXTENDED-SPECTRUM BETA-LACTAMASES OFHONG-KONG ISOLATES OF ENTEROBACTERIACEAE, Scandinavian journal of infectious diseases, 1996, pp. 17-20
Citation: Jm. Ling et al., SUSCEPTIBILITIES TO 23 ANTIMICROBIAL AGENTS AND BETA-LACTAMASE PRODUCTION OF BLOOD CULTURE ISOLATES OF ACINETOBACTER SP IN HONG-KONG, Scandinavian journal of infectious diseases, 1996, pp. 21-25
Citation: Tkc. Ng et al., A RETROSPECTIVE STUDY OF CLINICAL CHARACTERISTICS OF ACINETOBACTER BACTEREMIA, Scandinavian journal of infectious diseases, 1996, pp. 26-32
Authors:
NORRBY SR
DORNBUSCH K
MOLINARI M
SASSELLA D
ATTI E
GEFVERT O
ZADOR R
PETROCCIONE A
CAIROLI C
FRANSSON G
DENSTEDTSTIGZELIUS I
BAKALL A
OLSSON E
WIBERG PO
BABRA M
GASEB M
PAVEK E
JOHANSSON S
BERGSTAD B
VONKRAEMER S
THORELL NI
GRUNDESTAM I
FORSBERG G
ALMQVIST G
TILLING B
GNARPE H
SCHWAN A
SOREN L
Citation: Sr. Norrby et al., INTERPRETATION OF THE BACTERIOLOGICAL OUTCOME OF ANTIBIOTIC-TREATMENTFOR UNCOMPLICATED CYSTITIS - IMPACT OF THE DEFINITION OF SIGNIFICANT BACTERIURIA IN A COMPARISON OF RITIPENEM ACOXIL WITH NORFLOXACIN, Clinical infectious diseases, 20(3), 1995, pp. 507-513
Citation: Sr. Norrby et al., SAFETY PROFILE OF MEROPENEM - INTERNATIONAL CLINICAL-EXPERIENCE BASEDON THE FIRST 3125 PATIENTS TREATED WITH MEROPENEM, Journal of antimicrobial chemotherapy, 36, 1995, pp. 207-223
Citation: J. Wistrom et Sr. Norrby, FLUOROQUINOLONES AND BACTERIAL ENTERITIS, WHEN AND FOR WHOM, Journal of antimicrobial chemotherapy, 36(1), 1995, pp. 23-39
Authors:
RYLANDER M
ROLLOF J
JACOBSSON K
NORRBY SR
Citation: M. Rylander et al., COMPARATIVE ANTIBACTERIAL ACTIVITY OF L-695,256, A CARBAPENEM ACTIVE AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCI, Antimicrobial agents and chemotherapy, 39(5), 1995, pp. 1178-1181